13F filer · CIK 1040273 ↗
Third Point
You are looking at Q4 2016. See the latest, Q2 2026 →
Reported value
$10.19B
−11% on the quarter before
Positions
38
12 new · 12 sold out
Top 10
62.4%
of the value
Est. gain
−$156.0M
on stocks held all quarter
Est. return
−2.0%
on those stocks since Q3 2016
Positions as of Dec 31, 2016, from Third Point's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q3 2016. Striped tiles are options.
Largest buys
Since Q3 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Jpmorgan Chase & Co~$453.0MNew · 0.0% → 4.4%+5,250,000 shares
- Bank Amer Corp~$386.8MNew · 0.0% → 3.8%+17,500,000 shares
- Time Warner Inc~$289.6MNew · 0.0% → 2.8%+3,000,000 shares
- Zayo Group Hldgs Inc~$230.0MNew · 0.0% → 2.3%+7,000,000 shares
- Humana Inc~$204.0MAdded · 2.2% → 4.8%+1,000,000 shares
- Privatebancorp Inc~$162.6MNew · 0.0% → 1.6%+3,000,000 shares
- Honeywell Technologies~$159.3MNew · 0.0% → 1.6%+1,375,000 shares
- Anthem Inc~$143.8MNew · 0.0% → 1.4%+1,000,000 shares
- Constellation Brands Inc~$122.6MAdded · 3.2% → 4.5%+800,000 shares
- Goldman Sachs~$95.8MNew · 0.0% → 0.9%+400,000 shares
Largest sells
Since Q3 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Allergan Plc~$871.7MSold out · 7.6% → 0.0%−3,785,000 shares
- Alibaba~$275.1MSold out · 2.4% → 0.0%−2,600,000 shares
- Monsanto Co New~$273.5MCut · 3.3% → 1.1%−2,600,000 shares
- Meta~$224.3MCut · 6.1% → 4.0%−1,950,000 shares
- Transdigm Group Inc~$219.3MCut · 2.8% → 0.6%−881,000 shares
- Anheuser Busch Inbev Sa/Nv~$210.3MSold out · 1.8% → 0.0%−1,600,000 shares
- St Jude Med Inc~$207.4MSold out · 1.8% → 0.0%−2,600,000 shares
- Shire Plc~$174.5MSold out · 1.5% → 0.0%−900,000 shares
- Visa Inc.~$173.7MSold out · 1.5% → 0.0%−2,100,000 shares
- Dow Chem Co~$171.7MCut · 9.0% → 9.5%−3,000,000 shares
Holdings
As of Dec 31, 2016. Changes are in shares against Sep 30, 2016, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Intl IncCOM · shares 0% · price −6.8% | 22.6% | $2.30B | −$169.2M | ||||||||
| Dow Chem CoCOM · shares −15% · price +10.4% | 9.5% | $972.7M | +$91.6M | ||||||||
| Humana IncCOM · shares +71% · price +15.3% | 4.8% | $489.7M | +$38.0M | ||||||||
| Constellation Brands IncCL A · shares +36% · price −7.9% | 4.5% | $459.9M | −$29.0M | ||||||||
| Jpmorgan Chase & CoCOM · shares New | 4.4% | $453.0M | — | ||||||||
| MetaCL A · shares −36% · price −10.3% | 4.0% | $402.7M | −$46.3M | ||||||||
| Bank Amer CorpCOM · shares New | 3.8% | $386.8M | — | ||||||||
| AlphabetCAP STK CL A · shares −23% · price −1.4% | 3.3% | $336.8M | −$4.9M | ||||||||
| Time Warner IncCOM NEW · shares New | 2.8% | $289.6M | — | ||||||||
| Sherwin Williams CoCOM · shares +14% · price −2.9% | 2.6% | $268.7M | −$6.9M | ||||||||
| SothebysCOM · shares 0% · price +4.8% | 2.6% | $265.5M | +$12.3M | ||||||||
| Danaher Corp DelCOM · shares −28% · price −0.7% | 2.5% | $253.0M | −$1.8M | ||||||||
| Charter Communications Inc NCL A · shares −15% · price +6.6% | 2.4% | $244.7M | +$15.3M | ||||||||
| Mohawk Inds IncCOM · shares +33% · price −0.3% | 2.4% | $239.6M | −$594,000 | ||||||||
| Zayo Group Hldgs IncCOM · shares New | 2.3% | $230.0M | — | ||||||||
| General Dynamics CorpCOM · shares −3.7% · price +11.3% | 2.2% | $224.5M | +$22.8M | ||||||||
| AppleCOM · shares −26% · price +2.5% | 2.1% | $214.3M | +$5.1M | ||||||||
| S&P Global IncCOM · shares −20% · price −15.0% | 1.7% | $172.1M | −$30.4M | ||||||||
| Molson Coors Brewing CoCL B · shares 0% · price −11.4% | 1.6% | $165.4M | −$21.2M | ||||||||
| Privatebancorp IncCOM · shares New | 1.6% | $162.6M | — | ||||||||
| Honeywell TechnologiesCOM · shares New | 1.6% | $159.3M | — | ||||||||
| Chubb LimitedCOM · shares −33% · price +5.1% | 1.6% | $158.5M | +$7.8M | ||||||||
| Anthem IncCOM · shares New | 1.4% | $143.8M | — | ||||||||
| Dell Technologies IncCOM CL V · shares +13% · price +15.0% | 1.4% | $142.9M | +$16.5M | ||||||||
| Union Pac CorpCOM · shares −8.0% · price +6.3% | 1.2% | $119.2M | +$7.1M | ||||||||
| Total · 38 positions | 100% | $10.19B | −$156.0M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2016 to Q4 2016: 26 stocks held throughout, down $156.0M (−2.0%).
- Dow Chem Co+$91.6M+10%
- Humana Inc+$38.0M+15%
- General Dynamics Corp+$22.8M+11%
- Dell Technologies Inc+$16.5M+15%
- Charter Communications Inc N+$15.3M+7%
- Nomad Hldgs Ltd−$26.9M−19%
- Constellation Brands Inc−$29.0M−8%
- S&P Global Inc−$30.4M−15%
- Meta−$46.3M−10%
- Baxter Intl Inc−$169.2M−7%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $4.68B+125% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $2.08B−71% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $7.27B−19% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $8.99B+18% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $7.62B+16% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $6.55B−12% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $7.44B+0% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $7.43B−15% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $8.74B+11% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $7.85B+18% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $6.64B+1% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $6.59B−3% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $6.82B+12% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $6.11B+2% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $5.97B+8% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $5.53B+31% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $4.22B−45% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $7.68B−46% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $14.33B−22% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $18.32B+7% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $17.08B+15% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $14.84B+14% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $12.97B+30% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $10.00B+37% | SEC ↗ |
| Q2 2020 | Aug 17, 2020 | $7.30B+17% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $6.27B−28% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $8.70B+3% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $8.42B−1% | SEC ↗ |
| Q2 2019 | Aug 12, 2019 | $8.54B−5% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $8.99B+38% | SEC ↗ |
| Q4 2018 | Feb 8, 2019 | $6.51B−55% | SEC ↗ |
| Q3 2018 | Nov 9, 2018 | $14.31B−0% | SEC ↗ |
| Q2 2018 | Aug 10, 2018 | $14.35B+8% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $13.32B−4% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $13.86B+16% | SEC ↗ |
| Q3 2017 | Nov 9, 2017 | $11.90B+5% | SEC ↗ |
| Q2 2017 | Aug 11, 2017 | $11.28B+10% | SEC ↗ |
| Q1 2017 | May 12, 2017 | $10.25B+1% | SEC ↗ |
| Q4 2016 | Feb 10, 2017 | $10.19B−11% | SEC ↗ |
| Q3 2016 | Nov 10, 2016 | $11.50B+10% | SEC ↗ |
| Q2 2016 | Aug 12, 2016 | $10.49B−3% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $10.86B | SEC ↗ |